| Literature DB >> 30530601 |
Qi-Wei Chen1, Kai Dong1, Han-Xiao Qin1, Yi-Kai Yang2, Jin-Lei He1, Jiao Li1, Zhi-Wan Zheng1, Da-Li Chen1, Jian-Ping Chen3,4.
Abstract
Toxoplasma gondii is one of the most widespread obligatory parasitic protozoa and infects nearly all warm-blooded animals, leading to toxoplasmosis. The therapeutic drugs currently administered, like the combination of pyrimethamine and sulfadiazine, show high rates of toxic side effects, and drug resistance is encountered in some cases. Resveratrol is a natural plant extract with multiple functions, such as antibacterial, anticancer, and antiparasite activities. In this study, we evaluated the inhibitory effects of resveratrol on tachyzoites of the Toxoplasma gondii RH strain extracellularly and intracellularly. We demonstrate that resveratrol possesses direct antitoxoplasma activity by reducing the population of extracellularly grown tachyzoites, probably by disturbing the redox homeostasis of the parasites. Moreover, resveratrol was also able to release the burden of cellular stress, promote apoptosis, and maintain the autophagic status of macrophages, which turned out to be regulated by intracellular parasites, thereby functioning indirectly in eliminating T. gondii In conclusion, resveratrol has both direct and indirect antitoxoplasma effects against RH tachyzoites and may possess the potential to be further evaluated and employed for toxoplasmosis treatment.Entities:
Keywords: Toxoplasma gondiizzm321990; apicomplexan parasites; host-parasite relationship; intracellular parasites; resveratrol
Mesh:
Substances:
Year: 2019 PMID: 30530601 PMCID: PMC6395936 DOI: 10.1128/AAC.01233-18
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191